Mirum Pharmaceuticals, Inc. - common stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 05/08/2026 | Mar 2026Filed 05/08/2026 | Sep 2025Filed 04/11/2025 | Jun 2025Filed 05/08/2026 | Mar 2025Filed 05/08/2026 | Sep 2024Filed 04/11/2025 | Jun 2024Filed 04/11/2025 | Mar 2024Filed 04/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $176 | $160 | $133 | $128 | $112 | $90 | $78 | $69 | |
| −$67 | −$790 | $2.9 | −$5.9 | −$15 | −$14 | −$25 | −$25 | |
| −$1.06 | −$13.43 | $0.05 | −$0.12 | −$0.30 | −$0.30 | −$0.52 | −$0.54 | |
| 63 | 59 | 57 | 50 | 49 | 48 | 47 | 47 |
Trend